Saturday 17 October 2026
Export ATRC’s income statement to Excel — free account
AtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
56.09
1.69
−2.92%
Follow ATRC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.64 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 4 | 5 | 2 | 4 | 4 | 3 | 6 | 4 | 7 |
P/S ratio |
3.91 | 3.42 | 5.17 | 5.29 | 11.35 | 11.42 | 6.21 | 4.10 | 3.08 | 3.53 |
Altman Z-Score |
2.87 | 2.72 | 5.72 | 2.07 | 4.53 | 14.67 | 9.33 | 6.78 | 5.81 | 7.31 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 103.31 |
Altman Z″-Score (non-manufacturers) |
(0.12) | (0.56) | 2.33 | (0.12) | 1.87 | 4.47 | 3.18 | 3.17 | 2.76 | 3.44 |
Beneish M-Score |
(2.88) | (2.73) | (2.70) | (2.28) | (2.85) | (1.75) | (2.24) | (2.60) | (2.80) | (2.91) |
P/Operating CF |
797.49 | 391.48 | 1,058.95 | (346.28) | 593.10 | 10,410.10 | 44,586.56 | 405.86 | 245.93 | 94.32 |
P/B ratio |
3.60 | 3.71 | 4.18 | 4.94 | 5.69 | 6.48 | 4.49 | 3.51 | 3.11 | 3.84 |
Price to Tangible BV |
54.90 | 116.27 | 10.99 | 0.00 | 47.46 | 15.21 | 11.23 | 9.77 | 8.46 | 9.03 |
EV/Sales |
3.89 | 3.45 | 4.81 | 5.26 | 10.49 | 11.25 | 6.06 | 3.96 | 3.00 | 3.40 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.41 | 0.00 | 0.00 | 0.00 | 157.03 |
EV/Operating CF |
(39.86) | (67.43) | (232.30) | (76.77) | (109.07) | (223.94) | (90.39) | 352.28 | 114.31 | 31.67 |
EV/FCF |
(26.42) | (39.35) | (93.38) | (43.42) | (86.24) | (131.13) | (51.29) | (42.11) | (47.73) | 99.30 |
Quick Ratio |
2.26 | 1.80 | 3.72 | 2.20 | 5.44 | 2.69 | 2.81 | 2.55 | 2.49 | 2.87 |
Current Ratio |
2.97 | 2.58 | 4.34 | 2.87 | 6.24 | 3.47 | 3.69 | 3.57 | 3.65 | 3.96 |
Net Debt/EBITDA |
0.24 | (0.19) | 8.75 | 0.34 | 5.41 | (0.31) | 1.71 | 7.13 | 2.94 | (9.13) |
Debt/Assets |
14.07% | 13.98% | 14.70% | 13.20% | 9.26% | 11.63% | 12.20% | 9.87% | 10.15% | 9.46% |
Debt/Equity |
0.23 | 0.23 | 0.21 | 0.30 | 0.16 | 0.15 | 0.16 | 0.13 | 0.13 | 0.13 |
Asset Turnover |
0.56 | 0.64 | 0.65 | 0.50 | 0.32 | 0.41 | 0.55 | 0.67 | 0.76 | 0.85 |
Operating CF/Net income |
0.45 | 0.33 | 0.20 | 0.45 | 0.41 | (0.27) | 0.48 | (0.15) | (0.27) | (5.01) |
Capex/Depreciation |
(0.80) | (0.68) | (0.70) | (1.38) | (0.47) | (0.10) | (1.23) | (0.75) | (0.59) | (0.43) |
Interest Coverage |
(17.29) | (11.03) | (3.72) | (8.06) | (9.05) | 11.23 | (8.56) | (3.85) | (6.25) | (1.61) |
| (18.78%) | (16.32%) | (10.30%) | (14.17%) | (14.60%) | 11.20% | (9.88%) | (6.60%) | (9.64%) | (2.40%) | |
| (12.13%) | (9.88%) | (6.77%) | (7.70%) | (7.57%) | 7.55% | (7.74%) | (5.08%) | (7.31%) | (1.81%) | |
ROIC |
(11.92%) | (9.51%) | (6.03%) | (8.66%) | (11.80%) | 7.91% | (6.55%) | (4.28%) | (6.25%) | (1.53%) |
Return on Tangible Assets |
(38.37%) | (34.00%) | (13.08%) | (27.96%) | (16.84%) | 29.35% | (23.75%) | (13.00%) | (18.93%) | (4.09%) |
Average Days of Receivables |
49.64 | 48.22 | 45.61 | 44.35 | 40.91 | 43.94 | 47.17 | 48.00 | 47.33 | 45.51 |
Research and Development Expense of Revenue |
23.10% | 19.54% | 17.22% | 17.86% | 20.85% | 17.68% | 17.35% | 18.51% | 20.67% | 18.56% |
Selling, General and Administrative Expense of Revenue |
68.61% | 66.96% | 64.24% | 72.42% | 73.03% | 74.60% | 70.00% | 63.40% | 62.62% | 58.19% |
Intangible Assets out of Total Assets |
0.57 | 0.58 | 0.43 | 0.65 | 0.51 | 0.45 | 0.47 | 0.49 | 0.48 | 0.43 |
Share Based Compensation of Revenue |
7.54% | 8.37% | 8.18% | 7.79% | 10.96% | 10.24% | 8.71% | 8.95% | 8.68% | 8.36% |
Graham Net Nets |
(0.04) | (0.04) | 0.06 | (0.14) | 0.00 | 0.02 | 0.04 | 0.07 | 0.08 | 0.08 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(5.47%) | (4.49%) | (2.06%) | (2.86%) | (2.07%) | 1.60% | (2.25%) | (1.87%) | (3.11%) | (0.60%) |
Free Cash Flow Yield |
(3.76%) | (2.56%) | (0.99%) | (2.29%) | (1.07%) | (0.75%) | (1.90%) | (2.29%) | (2.04%) | 0.97% |
Revenue per Share |
4.91 | 5.39 | 5.92 | 6.14 | 4.90 | 6.09 | 7.22 | 8.62 | 9.91 | 11.19 |
Operating CF per Share |
(0.48) | (0.28) | (0.12) | (0.42) | (0.47) | (0.31) | (0.48) | 0.10 | 0.26 | 1.20 |
Capex per Share |
(0.24) | (0.20) | (0.18) | (0.32) | (0.12) | (0.22) | (0.37) | (0.26) | (0.24) | (0.19) |
Free Cash Flow per Share |
(0.72) | (0.47) | (0.30) | (0.74) | (0.60) | (0.52) | (0.85) | (0.16) | 0.02 | 1.01 |
Cash per Share |
1.39 | 1.06 | 3.65 | 2.18 | 5.80 | 2.64 | 2.65 | 2.96 | 2.61 | 3.51 |
Shareholders Equity per Share |
5.33 | 4.98 | 7.32 | 6.58 | 9.79 | 10.73 | 9.99 | 10.07 | 9.82 | 10.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.33 | 4.98 | 7.32 | 6.58 | 9.79 | 10.73 | 9.99 | 10.07 | 9.82 | 10.30 |
Free Cash Flow |
(22.81) | (15.33) | (10.38) | (27.95) | (25.13) | (23.53) | (39.02) | (7.51) | 0.77 | 48.28 |
Working Capital |
56.89 | 50.36 | 134.46 | 93.24 | 257.60 | 139.63 | 156.82 | 191.68 | 194.40 | 241.00 |
Capital Expenditures |
(7.69) | (6.38) | (6.20) | (12.14) | (5.26) | (9.75) | (16.88) | (12.00) | (11.43) | (9.05) |
Net Current Asset Value |
(22.26) | (24.28) | 67.30 | (167.38) | 4.59 | 64.52 | 86.52 | 118.48 | 119.47 | 160.27 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 55.90 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.05 | 0.03 | 0.04 | 0.05 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 56.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.33 | 0.33 | 0.27 | 0.40 | 3.06 | 0.35 | 0.38 | 0.46 | 0.54 |
Cash ROIC |
(9.07%) | (6.58%) | (2.43%) | (6.94%) | (3.48%) | (3.49%) | (6.01%) | (1.13%) | 0.12% | 6.69% |
Accounts Receivable Turnover |
7.66 | 7.91 | 8.35 | 8.67 | 8.07 | 9.77 | 8.73 | 8.39 | 8.25 | 8.42 |
Accounts Payable Turnover |
3.76 | 4.20 | 4.94 | 4.92 | 4.13 | 4.37 | 4.39 | 4.19 | 4.50 | 5.31 |
Inventory Turnover |
2.49 | 2.42 | 2.43 | 2.33 | 1.78 | 1.85 | 1.99 | 1.74 | 1.64 | 1.74 |
Average Days of Payables |
88.52 | 93.45 | 64.68 | 90.22 | 81.24 | 99.14 | 86.01 | 100.98 | 77.57 | 69.07 |
Days of Inventory on Hand |
146.47 | 168.78 | 150.55 | 177.54 | 223.42 | 207.71 | 198.54 | 250.64 | 233.46 | 214.20 |
Average Receivables |
20.25 | 22.09 | 24.14 | 26.62 | 25.60 | 28.08 | 37.86 | 47.60 | 56.42 | 63.50 |
Average Payables |
11.71 | 11.55 | 11.05 | 12.30 | 13.84 | 15.67 | 19.25 | 23.63 | 26.19 | 25.17 |
Average Inventory |
17.66 | 20.06 | 22.47 | 25.95 | 32.22 | 37.00 | 42.45 | 56.91 | 71.62 | 76.91 |
Average Assets |
274.76 | 272.06 | 312.23 | 457.32 | 636.21 | 664.93 | 600.38 | 599.69 | 611.63 | 631.75 |
Average Common Equity |
177.56 | 164.80 | 205.27 | 248.36 | 329.87 | 448.08 | 470.26 | 461.46 | 463.57 | 476.45 |
Columns are period end dates